Physician profile
Patrick T Hook
NPI 1548420896
$590.29
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.41 · 2021: $135 · 2022: $230 · 2023: $120 · 2024: $77.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $134.78 | 2021-2022 | |
| Janssen Biotech, INC. | $100.29 | 2020-2024 | Stelara, Remicade, Simponi Aria |
| Urovant Sciences INC | $42.47 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $40.60 | 2022-2023 | Fasenra |
| Sumitomo Pharma America, INC. | $40.14 | 2023 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.83 | 2022 | |
| Amgen INC. | $27.73 | 2022 | |
| Boston Scientific Corporation | $26.77 | 2022 | |
| Coloplast Corp | $24.67 | 2021 | |
| Accord Healthcare, INC. | $21.50 | 2023 | |
| Antares Pharma, INC. | $21.37 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.53 | 2021 | |
| Merck Sharp & Dohme LLC | $17.89 | 2021 | |
| Genzyme Corporation | $15.21 | 2024 | |
| Tolmar, INC. | $14.77 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $13.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.